Home › Companies › ELEVANCE HEALTH INC. › 2024-2025

ELEVANCE HEALTH INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ELEVANCE HEALTH INC.’s Form 8-K, filed May 14, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

6Ballot items
1,194Asset managers
8,048Fund votes
May 14, 2025Meeting date

Results at a glance

Meeting of May 14, 2025: 6 items on ELEVANCE HEALTH INC.’s Form 8-K, filed May 14, 2025: 3 elected · 2 approved · 1 not approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ELEVANCE HEALTH INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ELEVANCE HEALTH INC.

These tallies are ELEVANCE HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ELEVANCE HEALTH INC. — official shareholder meeting results, meeting held May 14, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Susan D. DeVore	185,839,586	3,726,860	158,903	--	11,942,703	98%	Elected	—
Elect Director: Bahija Jallal	180,810,837	8,752,093	162,419	--	11,942,703	95%	Elected	—
Elect Director: Ryan M. Schneider	184,627,201	4,951,857	146,291	--	11,942,703	97%	Elected	—
2. Advisory vote on the Company's executive compensation	173,964,580	15,522,459	238,310	--	11,942,703	92%	Approved	—
3. Ratification of the appointment of Ernst & Young LLP	178,086,607	23,455,317	126,128	--	--	88%	Approved	—
4. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts	26,240,205	160,685,853	2,799,291	--	11,942,703	14%	Not approved	—

Source: ELEVANCE HEALTH INC., Form 8-K, filed with the SEC on May 14, 2025 — read the filing on EDGAR.

How asset managers voted at the ELEVANCE HEALTH INC. 2024-2025 meeting

Each item below shows how the 1,194 asset managers that disclosed a ELEVANCE HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Bahija Jallal

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 180,810,837AGAINST: 8,752,093

Details: description as filed, official tally, votes by 211 asset managers

Description as filed by funds: Election of Directors: Bahija Jallal

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Bahija Jallal”): 180,810,837 for, 8,752,093 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 211 asset managers below reported 71,916,250 for, 1,738,896 against, 17,590 abstained.

FOR

FOR: 71,916,250AGAINST: 1,738,896ABSTAIN: 17,590

Largest asset managers voting on “Election of Directors: Bahija Jallal” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	21,455,588	3	For
BlackRock	7,179,332	0	For
Fidelity	5,329,206	0	For
T. Rowe Price	4,544,953	4,745	For
Capital Group	4,089,010	0	For
State Street	2,438,236	0	For
FIRST EAGLE FUNDS	2,437,343	0	For
MFS	1,828,454	0	For
Charles Schwab	1,712,757	0	For
Invesco	0	1,555,935	Against
Dimensional	1,394,209	0	For
TIAA	1,382,693	0	For
HARRIS ASSOCIATES INVESTMENT TRUST	1,329,502	0	For
Hartford	1,197,678	198	For
FRANKLIN MUTUAL SERIES FUNDS	1,144,770	0	For
Columbia Threadneedle	1,080,718	0	For
First Trust	945,280	0	For
John Hancock	930,168	0	For
GMO	780,591	0	For
INVESTMENT CO OF AMERICA	566,783	0	For
AMCAP FUND	523,858	0	For
Victory Capital	515,402	0	For
Jackson National	510,835	0	For
Bridge Builder Trust	473,801	0	For
JPMorgan	466,391	0	For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

2. Elect Director: Ryan M. Schneider

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 184,627,201AGAINST: 4,951,857

Details: description as filed, official tally, votes by 211 asset managers

Description as filed by funds: Election of Directors: Ryan M. Schneider

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Ryan M. Schneider”): 184,627,201 for, 4,951,857 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 211 asset managers below reported 73,602,584 for, 52,562 against, 17,589 abstained.

FOR

FOR: 73,602,584AGAINST: 52,562ABSTAIN: 17,589

Largest asset managers voting on “Election of Directors: Ryan M. Schneider” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	21,455,590	2	For
BlackRock	7,179,332	0	For
Fidelity	5,329,206	0	For
T. Rowe Price	4,544,953	4,745	For
Capital Group	4,089,010	0	For
State Street	2,438,236	0	For
FIRST EAGLE FUNDS	2,437,343	0	For
MFS	1,828,454	0	For
Charles Schwab	1,712,757	0	For
Invesco	1,555,935	0	For
Dimensional	1,394,209	0	For
TIAA	1,382,693	0	For
HARRIS ASSOCIATES INVESTMENT TRUST	1,329,502	0	For
Hartford	1,197,876	0	For
FRANKLIN MUTUAL SERIES FUNDS	1,144,770	0	For
Columbia Threadneedle	1,080,718	0	For
First Trust	945,280	0	For
John Hancock	930,168	0	For
GMO	780,591	0	For
INVESTMENT CO OF AMERICA	566,783	0	For
AMCAP FUND	523,858	0	For
Victory Capital	515,402	0	For
Jackson National	510,835	0	For
Bridge Builder Trust	473,801	0	For
JPMorgan	466,391	0	For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

3. Elect Director: Susan D. DeVore

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 185,839,586AGAINST: 3,726,860

Details: description as filed, official tally, votes by 211 asset managers

Description as filed by funds: Election of Directors: Susan D. DeVore

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Susan D. DeVore”): 185,839,586 for, 3,726,860 against, per its Form 8-K filed May 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2028 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 211 asset managers below reported 71,525,400 for, 2,124,284 against, 23,052 abstained.

FOR

FOR: 71,525,400AGAINST: 2,124,284ABSTAIN: 23,052

Largest asset managers voting on “Election of Directors: Susan D. DeVore” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	21,455,590	2	For
BlackRock	7,179,332	0	For
Fidelity	5,329,206	0	For
T. Rowe Price	4,546,451	3,247	For
Capital Group	4,089,010	0	For
State Street	2,438,236	0	For
FIRST EAGLE FUNDS	2,437,343	0	For
MFS	0	1,828,454	Against
Charles Schwab	1,712,757	0	For
Invesco	1,555,935	0	For
Dimensional	1,394,209	0	For
TIAA	1,382,693	0	For
HARRIS ASSOCIATES INVESTMENT TRUST	1,329,502	0	For
Hartford	1,197,876	0	For
FRANKLIN MUTUAL SERIES FUNDS	1,144,770	0	For
Columbia Threadneedle	1,080,718	0	For
First Trust	945,280	0	For
John Hancock	930,168	0	For
GMO	780,591	0	For
INVESTMENT CO OF AMERICA	566,783	0	For
AMCAP FUND	523,858	0	For
Victory Capital	515,402	0	For
Jackson National	510,835	0	For
Bridge Builder Trust	473,801	0	For
JPMorgan	466,391	0	For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

4. 2. Advisory vote on the Company's executive compensation

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 28 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%

FOR: 173,964,580AGAINST: 15,522,459

Details: description as filed, official tally, votes by 1,187 asset managers

Description as filed by funds: Advisory vote to approve the compensation of our named executive officers.

ELEVANCE HEALTH INC.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 173,964,580 for, 15,522,459 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (3 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 208 asset managers voting on “Advisory vote to approve the compensation of our named executive officers.” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	21,452,743	2,849	For
BlackRock	7,175,605	3,727	For
Fidelity	5,329,206	0	For
T. Rowe Price	4,546,451	3,247	For
Capital Group	4,089,010	0	For
State Street	2,437,881	355	For
FIRST EAGLE FUNDS	2,437,343	0	For
MFS	1,828,454	0	For
Charles Schwab	1,712,757	0	For
Invesco	1,555,935	0	For
Dimensional	1,394,209	0	For
TIAA	1,382,693	0	For
HARRIS ASSOCIATES INVESTMENT TRUST	1,329,502	0	For
Hartford	1,197,678	198	For
FRANKLIN MUTUAL SERIES FUNDS	1,144,770	0	For
Columbia Threadneedle	1,080,718	0	For
First Trust	945,280	0	For
John Hancock	930,168	0	For
GMO	780,591	0	For
INVESTMENT CO OF AMERICA	566,783	0	For
AMCAP FUND	523,858	0	For
Victory Capital	515,402	0	For
Jackson National	510,835	0	For
Bridge Builder Trust	473,801	0	For
JPMorgan	466,391	0	For

Fund voting reports, all 208 managers: 73,338,121 for, 353,867 against, 17,593 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1,014 asset managers voting on “Advisory vote to approve the compensation of our named executive officers.” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	9,138,602	7,548	For
T. Rowe Price	9,132,476	12,299	For
State Street	6,474,590	355	For
Wellington	5,251,867	0	For
Capital Group	5,228,820	100	For
GEODE CAPITAL MANAGEMENT, LLC	5,112,867	0	For
Artisan	3,102,425	0	For
First Eagle Investment Management, LLC	2,910,534	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	2,699,040	0	For
Sanders Capital, LLC	2,601,433	0	For
Orbis Allan Gray Ltd	2,349,420	0	For
Northern Trust	2,052,277	0	For
Nuveen	1,935,226	0	For
Invesco	1,901,271	0	For
HARRIS ASSOCIATES L P	1,900,210	0	For
Grantham, Mayo, Van Otterloo & Co. LLC	1,869,670	0	For
Charles Schwab	1,743,987	0	For
AllianceBernstein	1,664,120	0	For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	1,628,432	0	For
Brave Warrior Advisors, LLC	0	1,602,021	Against
Fidelity	1,534,183	0	For
John Hancock	1,506,057	0	For
UBS	1,334,455	25,250	For
EdgePoint Investment Group Inc.	1,275,560	0	For
FRANKLIN MUTUAL ADVISERS LLC	1,192,648	0	For

Institutional-manager reports, all 1,014 managers: 114,600,276 for, 11,614,645 against, 1,024 abstained, 54,930 not voted, 7,224 unknown. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of the appointment of Ernst & Young LLP

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

88% Approved · of votes cast

FOR 88%

FOR: 178,086,607AGAINST: 23,455,317

Details: description as filed, official tally, votes by 212 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025.

ELEVANCE HEALTH INC.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 178,086,607 for, 23,455,317 against — passed, per its Form 8-K filed May 14, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025 was ratified based upon the following votes:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (11 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 212 asset managers below reported 72,098,924 for, 1,422,064 against, 17,587 abstained.

FOR

FOR: 72,098,924AGAINST: 1,422,064ABSTAIN: 17,587

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025.” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	20,345,763	1,109,829	Mixed
BlackRock	7,179,332	0	For
Fidelity	5,329,206	0	For
T. Rowe Price	4,549,698	0	For
Capital Group	4,089,010	0	For
State Street	2,438,200	36	For
FIRST EAGLE FUNDS	2,437,343	0	For
MFS	1,828,454	0	For
Charles Schwab	1,712,757	0	For
Invesco	1,555,935	0	For
Dimensional	1,394,209	0	For
TIAA	1,382,693	0	For
HARRIS ASSOCIATES INVESTMENT TRUST	1,329,502	0	For
Hartford	1,197,678	198	For
FRANKLIN MUTUAL SERIES FUNDS	1,144,770	0	For
Columbia Threadneedle	1,080,718	0	For
First Trust	945,280	0	For
John Hancock	930,168	0	For
GMO	780,591	0	For
INVESTMENT CO OF AMERICA	566,783	0	For
AMCAP FUND	523,858	0	For
Victory Capital	515,402	0	For
Jackson National	510,835	0	For
Bridge Builder Trust	473,801	0	For
JPMorgan	466,391	0	For

Showing the 25 largest of 212 asset managers. See all 212 in the interactive database.

6. 4. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts

Official resultDIVERSITY, EQUITY, AND INCLUSIONReported outcome: Not approved

Combines 9 wordings of this item as funds reported it.

14% Not approved · of votes cast

FOR 14%AGAINST

FOR: 26,240,205AGAINST: 160,685,853

Details: description as filed, official tally, votes by 213 asset managers

Description as filed by funds: Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.

ELEVANCE HEALTH INC.’s own tally for this item (“4. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts”): 26,240,205 for, 160,685,853 against — failed, per its Form 8-K filed May 14, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting a report on the effectiveness of Diversity, Equity, and Inclusion efforts was not approved based upon the following votes:”
Support: 14% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 213 asset managers below reported 2,688,391 for, 69,761,149 against, 1 withheld, 1,222,527 abstained.

AGAINST

FOR: 2,688,391AGAINST: 69,761,149ABSTAIN: 1,222,527WITHHOLD: 1

Largest asset managers voting on “Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.” at ELEVANCE HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	943,114	20,512,477	1	Against
BlackRock	4,668	7,174,664	0	Against
Fidelity	1,218	5,327,988	0	Against
T. Rowe Price	0	4,549,698	0	Against
Capital Group	0	4,089,010	0	Against
State Street	451	2,437,785	0	Against
FIRST EAGLE FUNDS	0	2,437,343	0	Against
MFS	0	1,828,454	0	Against
Charles Schwab	0	1,712,757	0	Against
Invesco	0	1,555,935	0	Against
Dimensional	0	1,394,209	0	Against
TIAA	0	1,382,693	0	Against
HARRIS ASSOCIATES INVESTMENT TRUST	0	1,329,502	0	Against
Hartford	198	1,197,678	0	Against
FRANKLIN MUTUAL SERIES FUNDS	0	1,144,770	0	Against
Columbia Threadneedle	0	0	1,080,718	Abstain
First Trust	0	945,280	0	Against
John Hancock	243,207	686,961	0	Mixed
GMO	0	780,591	0	Against
INVESTMENT CO OF AMERICA	0	566,783	0	Against
AMCAP FUND	0	523,858	0	Against
Victory Capital	0	515,402	0	Against
Jackson National	0	510,835	0	Against
Bridge Builder Trust	216,956	256,845	0	Mixed
JPMorgan	47	466,344	0	Against

Showing the 25 largest of 213 asset managers. See all 213 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 15, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest ELEVANCE HEALTH INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 225,641,361 shares outstanding at the time of that meeting.

Fund voting reports: top ELEVANCE HEALTH INC. shareholders by shares voted on “Advisory vote to approve the compensation of our named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	9.51%
2	BlackRock	3.18%
3	Fidelity	2.36%
4	T. Rowe Price	2.02%
5	Capital Group	1.81%
6	State Street	1.08%
7	FIRST EAGLE FUNDS	1.08%
8	MFS	0.81%
9	Charles Schwab	0.76%
10	Invesco	0.69%

Institutional-manager reports: top ELEVANCE HEALTH INC. shareholders by shares voted on “Advisory vote to approve the compensation of our named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	4.05%
2	T. Rowe Price	4.05%
3	State Street	2.87%
4	Wellington	2.33%
5	Capital Group	2.32%
6	GEODE CAPITAL MANAGEMENT, LLC	2.27%
7	Artisan	1.37%
8	First Eagle Investment Management, LLC	1.29%
9	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	1.20%
10	Sanders Capital, LLC	1.15%

Reported ELEVANCE HEALTH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ELEVANCE HEALTH INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	9.44%	13F
State Street	4.72%	13F
T. Rowe Price	4.05%	13F
Wellington Management	2.57%	13F
Morgan Stanley	1.32%	13F
Norges Bank	1.21%	13F
Northern Trust	1.08%	13F

Percentages above are of 225,641,361 shares outstanding, as reported by ELEVANCE HEALTH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELEVANCE HEALTH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At ELEVANCE HEALTH INC.'s shareholder meeting held May 14, 2025, in the 2024-2025 proxy season, 1,194 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 8,048 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve the compensation of our named executive officers. — ELEVANCE HEALTH INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ELEVANCE HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2025.

ELEVANCE HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.